Review
COX-2 inhibitors and the heart: putting risk in perspective
Affiliations
- PMID: 16295003
Item in Clipboard
Review
COX-2 inhibitors and the heart: putting risk in perspective
Adv Nurse Pract.
2005 Nov.
No abstract available
Similar articles
-
The COX-2 inhibitors--an update.Am Heart J. 2006 Aug;152(2):197-9. doi: 10.1016/j.ahj.2006.05.022. Am Heart J. 2006. PMID: 16875896 No abstract available.
-
Raising the safety bar--the FDA's coxib meeting.N Engl J Med. 2005 Mar 31;352(13):1283-5. doi: 10.1056/NEJMp058055. N Engl J Med. 2005. PMID: 15800221 No abstract available.
-
Coxibs and cardiovascular disease.N Engl J Med. 2004 Oct 21;351(17):1709-11. doi: 10.1056/NEJMp048288. Epub 2004 Oct 6. N Engl J Med. 2004. PMID: 15470192 No abstract available.
-
COX-2 selective inhibitors and heart health.Postgrad Med. 2005 Jan;117(1 Suppl):7-20. doi: 10.3810/pgm.01.2005.suppl40.201. Postgrad Med. 2005. PMID: 19667717 Review.
-
[Cardiovascular events: a class effect by COX-2 inhibitors].Arq Bras Cardiol. 2005 Sep;85(3):222-9. doi: 10.1590/s0066-782x2005001600016. Epub 2005 Sep 29. Arq Bras Cardiol. 2005. PMID: 16200274 Review. Portuguese. No abstract available.
Cited by
-
Inhibition of cyclooxygenase-2-dependent survivin mediates decursin-induced apoptosis in human KBM-5 myeloid leukemia cells.Cancer Lett. 2010 Dec 8;298(2):212-21. doi: 10.1016/j.canlet.2010.07.007. Epub 2010 Jul 31. Cancer Lett. 2010. PMID: 20673699 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials